Hippo-YAP/TAZ Signaling in Cancer

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Signaling".

Deadline for manuscript submissions: closed (30 April 2020) | Viewed by 219

Special Issue Editor


E-Mail Website
Guest Editor
EMBL Australia, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia
Interests: cancer; metastasis; YAP/TAZ; Hippo signaling; Integrin; Src; extracellular matrix; PI3K-Akt

Special Issue Information

Dear Colleagues,

I would like to invite you to join the open-access publishing revolution by submitting a manuscript from your lab to a Special Issue of Cells on Hippo-YAP/TAZ Signaling in Cancer. We are excited to publish any new work in this field from your lab.

YAP/TAZ oncogenes are emerging as key drivers of solid tumor formation and progression to metastasis, and are therefore interesting targets for cancer therapy.  Although YAP/TAZ are known to be regulated by the Hippo (MST-LATS) pathway, precisely how they become activated in cancer remains to be explored. There is potential for many cancer-relevant signals to affect Hippo-YAP/TAZ signaling, and we seek manuscripts that explore molecular mechanisms regulating this pathway in normal cells and tumors.

We look forward to your contribution.

Prof. Barry Thompson
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Hippo
  • YAP
  • TAZ
  • signaling
  • cancer
  • metastasis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop